Tempol improves neuroinflammation and delays motor dysfunction in a mouse model (SOD1G93A) of ALS

The development of new therapeutic strategies to treat amyotrophic lateral sclerosis (ALS) is of utmost importance. The use of cyclic nitroxides such as tempol may provide neuroprotection and improve lifespan....

Source: Journal of Neuroinflammation - November 14, 2019 Category: Neurology Authors: Gabriela Bortolan ça Chiarotto, Luciana Politti Cartarozzi, Matheus Perez, Natalia Perussi Biscola, Aline Barroso Spejo, Fernanda Gubert, Marcondes França Junior, Rosália Mendez-Otero and Alexandre Leite Rodrigues de Oliveira Tags: Research Source Type: research